Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Salomone, B; Ponti, R; Gasco, MR; Ugazio, E; Quaglino, P; Osella-Abate, S; Bernengo, MG
   In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: Evaluation of antiproliferative activity and apoptosis induction
   CLINICAL & EXPERIMENTAL METASTASIS
   
   B. Salomone et al., "In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: Evaluation of antiproliferative activity and apoptosis induction", CLIN EXP M, 18(8), 2001, pp. 663-673
2. Chang, JG; Hsieh-Li, HM; Jong, YJ; Wang, NM; Tsai, CH; Li, H
   Treatment of spinal muscular atrophy by sodium butyrate
   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
   
   J.G. Chang et al., "Treatment of spinal muscular atrophy by sodium butyrate", P NAS US, 98(17), 2001, pp. 9808-9813
3. Douillard, JY; Bennouna, J; Vavasseur, F; Deporte-Fety, R; Thomare, P; Giacalone, F; Meflah, K
   Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer
   CANCER IMMUNOLOGY IMMUNOTHERAPY
   
   J.Y. Douillard et al., "Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer", CANCER IMMU, 49(1), 2000, pp. 56-61
4. Pouillart, P; Douillet, O; Scappini, B; Gozzini, A; Santini, V; Grossi, A; Pagliai, G; Strippoli, P; Rigacci, L; Ronco, G; Villa, P
   Regioselective synthesis and biological profiling of butyric and phenylalkylcarboxylic esters derivated from D-mannose and xylitol: influence of alkyl chain length on acute toxicity
   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
   
   P. Pouillart et al., "Regioselective synthesis and biological profiling of butyric and phenylalkylcarboxylic esters derivated from D-mannose and xylitol: influence of alkyl chain length on acute toxicity", EUR J PH SC, 7(2), 1999, pp. 93-106
5. Egorin, MJ; Yuan, ZM; Sentz, DL; Plaisance, K; Eiseman, JL
   Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats
   CANCER CHEMOTHERAPY AND PHARMACOLOGY
   
   M.J. Egorin et al., "Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats", CANC CHEMOT, 43(6), 1999, pp. 445-453
6. BERKOVITCH M; SHER G; MCCLELAND R; MATSUI D; HADZIALIC G; OLIVIERI NF; KOREN G
   PHARMACOKINETICS OF ARGININE BUTYRATE IN PATIENTS WITH HEMOGLOBINOPATHY
   Environmental toxicology and pharmacology
   
   M. Berkovitch et al., "PHARMACOKINETICS OF ARGININE BUTYRATE IN PATIENTS WITH HEMOGLOBINOPATHY", Environmental toxicology and pharmacology, 2(4), 1996, pp. 403-405
7. BRETTMAN LR; CHATURVEDI PR
   PHARMACOKINETICS AND SAFETY OF SINGLE ORAL DOSES OF VX-366 (ISOBUTYRAMIDE) IN HEALTHY-VOLUNTEERS
   Journal of clinical pharmacology
   
   L.R. Brettman e P.R. Chaturvedi, "PHARMACOKINETICS AND SAFETY OF SINGLE ORAL DOSES OF VX-366 (ISOBUTYRAMIDE) IN HEALTHY-VOLUNTEERS", Journal of clinical pharmacology, 36(7), 1996, pp. 617-622
8. BUBLEY GJ; XU J; KUPIEC N; SANDERS D; FOSS F; OBRIEN M; EMI Y; TEICHER BA; PATIERNO SR
   EFFECT OF DNA CONFORMATION ON CISPLATIN ADDUCT FORMATION
   Biochemical pharmacology
   
   G.J. Bubley et al., "EFFECT OF DNA CONFORMATION ON CISPLATIN ADDUCT FORMATION", Biochemical pharmacology, 51(5), 1996, pp. 717-721
9. VINCENTFIQUET O; ROGEZ JC; BOITTE F; BRAZIER M; DESMET G
   EFFECTS OF ARGININE BUTYRATE AND TRIBUTYRYLXYLITOL ON CULTURED HUMAN SARCOMA-CELLS
   Anticancer research
   
   O. Vincentfiquet et al., "EFFECTS OF ARGININE BUTYRATE AND TRIBUTYRYLXYLITOL ON CULTURED HUMAN SARCOMA-CELLS", Anticancer research, 14(5A), 1994, pp. 1823-1828